These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 605744)

  • 21. Effect of glucose on the growth hormone response to L-dopa in normal and diabetic subjects.
    Ajlouni K; Martinson DR; Hagen TC
    Diabetes; 1975 Jul; 24(7):633-6. PubMed ID: 1158029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressive effect of cyproheptadine on L-DOPA-induced growth hormone release in man.
    Nakai Y; Imura H
    Endocrinol Jpn; 1975 Aug; 22(4):357-60. PubMed ID: 1201741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone secretion in insulin-independent pregnant diabetics.
    Notelovitz M; James S
    Obstet Gynecol; 1976 Apr; 47(4):449-53. PubMed ID: 943735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human growth hormone response to levodopa. Relation to menopause, depression, and plasma dopa concentration.
    Sachar EJ; Altman N; Gruen PH; Glassman A; Halpern FS; Sassin J
    Arch Gen Psychiatry; 1975 Apr; 32(4):502-3. PubMed ID: 1119901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):344-8. PubMed ID: 1345575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HGH response to dihydroxyphenylalanine (L-dopa) (author's transl)].
    Del Valle Núñez CJ; García Guerrero M; García De Pesquera F; Pérez Bryan J
    An Esp Pediatr; 1976; 9(2):174-9. PubMed ID: 937869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive effect of L-dopa on human prolactin release during sleep.
    Chihara K; Kato Y; Maeda K; Ohgo S; Imura H
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):19-27. PubMed ID: 174362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B; Reiner Z; Sekso M
    Exp Clin Endocrinol; 1983 Jan; 81(1):41-8. PubMed ID: 6343098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic responses to monocomponent human insulin infusions in normal subjects and patients with liver and endocrine disease.
    West TE; Owens D; Sönksen PH; Srivastava MC; Tompkins CV; Nabarro JD
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):573-84. PubMed ID: 1104216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human growth hormone (hGH) stimulation tests: the sequential exercise and L-dopa procedure.
    Liberman B; Cesar FP; Wajchenberg BL
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):649-54. PubMed ID: 476987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of impaired growth hormone secretion in patients with Cushing's disease.
    Takahashi H; Bando H; Zhang C; Yamasaki R; Saito S
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):13-7. PubMed ID: 1519417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone responses to the stimulation of hypothalamic glucoreceptors in diabetic retinopathy. Effects of catecholamine precursors and dopamine antagonists.
    Schaub C; Drouin P; Bluet-Pajot MT; Mejean L; Rousselle D
    Arch Neurol; 1982 May; 39(5):264-9. PubMed ID: 6280653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stimulation of growth hormone (HGH) with L-dopa].
    Gosselin L; Bolduc R; Verreault R
    Union Med Can; 1974 Sep; 103(9):1552-6. PubMed ID: 4439528
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth hormone levels in diabetes. Correlation with the clinical control of the disease.
    Vigneri R; Squatrito S; Pezzino V; Filetti S; Branca S; Polosa P
    Diabetes; 1976 Mar; 25(3):167-72. PubMed ID: 1254109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
    Camanni F; Massara F; Fassio V; Molinatti GM; Müller EE
    Neuroendocrinology; 1975; 19(3):227-40. PubMed ID: 1223659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioreceptor-inactive growth hormone associated with stimulated secretion in normal subjects.
    Sneid DS; Jacobs LS; Weldon VV; Trivedi BL; Daughaday H
    J Clin Endocrinol Metab; 1975 Sep; 41(3):471-4. PubMed ID: 169286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prolactin response to TRH in insulin-dependent diabetes mellitus].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1989-95. PubMed ID: 6779839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.